Q1 EPS Estimate for Corbus Pharmaceuticals Lifted by Analyst
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free Report) – HC Wainwright boosted their Q1 2025 EPS estimates for shares of Corbus Pharmaceuticals in a research report issued to clients and investors on Wednesday, March 12th. HC Wainwright analyst A. Maldonado now anticipates that the biopharmaceutical company will post earnings per share of ($0.98) for the […]
More Stories
‘When Will Markets React to Debt?’ Is the Wrong Question
By Veronique de Rugy Is the federal government’s history of enormous deficits proof that it can keep up the borrowing?...
Democratic Rep. Haley Stevens Endorses GOP’s Mike Rogers in Michigan Senate Race
By Tom Gantert Rep. Haley Stevens (D-Mich.) endorsed Republican Mike Rogers in the state’s U.S. Senate race, in a video...
Investors Look Past Profits as Big Tech Burns Cash Amid Heavy AI Spending
By Panos Mourdoukoutas Microsoft, Alphabet, and Amazon reported strong earnings last week, yet Wall Street wasn’t impressed. Shares of all...
France’s Far-Left Protests on Halloween Descend Into Violence as Unrest Spreads Across Europe
By Etienne Fauchaire PARIS—Tens of thousands of left-wing demonstrators marched along the eastern edge of Paris on Saturday, in a...
Judge Dismisses Trump’s Defamation Lawsuit Against Wall Street Journal Publisher
By Tom Gantert A federal judge on Oct. 31 dismissed President Donald Trump’s defamation lawsuit against The Wall Street Journal’s...
Cybersecurity Researchers Link North Korea to $6.4 Billion Binance Hack
By Ryan Morgan Private blockchain analysis companies TRM Labs and Chainalysis have both assessed that North Korean state-backed hackers were...